Antibiotic selection in the management of febrile neutropenia: Current approach and new directions
Braz. j. infect. dis
;
2(3): 109-17, Jun. 1998.
Artigo
em Inglês
| LILACS
| ID: lil-243406
RESUMO
The combination of neutropenia and fever, with or without documented infection, is a commun complication in cancer patients receiving chemotherapy. The prompt institution of empirical broad-spectrum antibiotic therapy for febrile neutropenic patients has been shown to reduce the rate of early death and morbidity in cancer populations undergoing chemotherapy. Three different regimens for considerations as initial empiric therapy are presented. Alternatives such as outpatient regimens to low risk patients and monotherapy are discussed. If confirmed prospectively, the results presented here may enable clinicians to identify low risk groups and treat neutropenia and fever with good results and better economic and psychological cost.
Buscar no Google
Índice:
LILACS (Américas)
Assunto principal:
Carbapenêmicos
/
Cefalosporinas
/
Agranulocitose
/
Avaliação de Medicamentos
/
Febre
/
Neoplasias
/
Neutropenia
/
Antineoplásicos
Tipo de estudo:
Estudo de etiologia
Limite:
Humanos
Idioma:
Inglês
Revista:
Braz. j. infect. dis
Assunto da revista:
Doenças Transmissíveis
Ano de publicação:
1998
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS